Published 2014 | Version v1
Journal article

Detection of homing-in of stem cells labeled with technetium-99m hexamethylpropyleneamine oxime in infarcted myocardium after intracoronary injection

  • 1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi (India)
  • 2. Department of Cardiology, All India Institute of Medical Sciences, New Delhi (India)
  • 3. Stem Cell Facility, All India Institute of Medical Sciences, New Delhi (India)

Description

Bone marrow stem cells having myogenic potential are promising candidates for various cell-based therapies for myocardial disease. We present here images showing homing of technetium-99m (Tc-99m) hexamethylpropyleneamine oxime (HMPAO) labeled stem cells in the infarcted myocardium from a pilot study conducted to radio-label part of the stem cells in patients enrolled in a stem cell clinical trial for recent myocardial infarction

Availability note (English)

Available from http://dx.doi.org/10.4103/0972-3919.142647; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228599

Additional details

Publishing Information

Journal Title
Indian Journal of Nuclear Medicine
Journal Volume
29
Journal Issue
4
Journal Page Range
p. 276-277
ISSN
0972-3919

Optional Information

Notes
PMCID: PMC4228599; PMID: 25400375; PUBLISHER-ID: IJNM-29-276; OAI: oai:pubmedcentral.nih.gov:4228599; Copyright: (c) Indian Journal of Nuclear Medicine; This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.